Endpoints News – Biotech, drug, pharma and health news for …
WEB23andMe CEO says she is no longer open to outside takeover offers. All of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing ...
Big dreams dominate among next-gen biotech players
WEBSep 22, 2024 · The Endpoints 11: Big dreams dominate among next-gen biotech players | Live Event + Livestream. Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a biotech. Here’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or …
News – Endpoints News
WEBEnara Bio’s $32.5M Series B to support lead dark antigen program for GI cancers. 2 days ago. Financing. R&D.
Endpoints News — Breaking: FDA issues landmark double …
WEBDec 8, 2023 · by Ryan Cross: In a 2008 issue of Science, just a page apart, were the two crucial discoveries that would form the cure for sickle cell disease.. Stuart Orkin, a hematologist at Boston Children’s Hospital, had published work identifying the genetic switch that could turn on backup copies of life-sustaining hemoglobin proteins in sick ...
Endpoints at #JPM22 - A look at what's to come in 2022
WEBEndpoints has been there to chronicle it with wall-to-wall coverage, and our founder and editor John Carroll has convened top newsmakers to provide detailed insights about their strategies. For #JPM22, Endpoints is expanding on our proud tradition with multiple panels addressing the most important issues in biopharma R&D. title sponsor.
Endpoints at #JPM24 | Primed to unlock biopharma's next …
WEBThe Endpoints Hub will be open for coworking & networking — power up your devices, check email and grab coffee and a bite between session. On Tuesday, you’ll go to biotech downturn survival school, hear about the data private investors expect to see in a tricky capital market and find out the future plans for pharma from top execs in the ...
Pharma channel feed - Endpoints News
WEBPfizer pulls sickle cell drug from all markets after data review showed rise in deaths and complications. 12 hours ago. FDA+.
Endpoints at #ASCO24
WEBJun 4, 2024 · Endpoints at #ASCO24. Tuesday, June 4, 2024. 11:00 AM - 1:40 PM. Each year, the oncology world looks to the ASCO meeting to make sense of the clinical cancer landscape. Data coming out of the meeting will signal pipeline strengths and weaknesses, and point to the next directions for cancer treatment. We’ll cover the biggest news out of …
ESMO23 | Cancer breakthroughs and barriers in oncology R&D
WEBAfter a decade of patient breakthroughs leveraging technologies like immunotherapy, ADCs and targeted therapies, cancer R&D is staring down its next era. Our expert panel will look at how the R&D landscape has shifted, new attempts to go after cancer's “undruggable” targets and how the field is thinking about where the goalposts are in what ...
Endpoints at #ESMO24
WEBSep 17, 2024 · Endpoints at #ESMO24. Endpoints at #ESMO24. Tuesday, September 17, 2024. 10:30 AM - 12:30 PM ЕТ. ESMO is the oncology conference to watch this year — the Endpoints team is on the ground reporting on the latest readouts and pipeline updates from the European cancer drug scene. What pathways and targets show promise?